Aims of the group

All EORTC GU Group activities are activities divided into clinical research and laboratory research conducted by a multidisciplinary group. The objectives of the EORTC GU Group are as follows:

To co-ordinate and promote multidisciplinary approach to research on urological cancer treatment through clinical urological cancer trials and where possible integrating translational research programmes. To this purpose novel and innovative trials that cover studies from early drug development up to large phase III clinical trials will be designed and executed looking at strategic therapeutic questions which will influence the urological cancer-related practice or improve fundamentally the understanding of the disease. Trials are conducted within the framework of the European Organisation for Research and Treatment of Cancer (EORTC) and/or within intergroup studies.

To develop, stimulate and co-ordinate clinical, translational and basic research studies in urological cancer within the framework of the European Organisation for Research and Treatment of Cancer (EORTC) and/or within intergroup studies.

To encourage scientific research in urological cancer, support the collaboration between basic medical research scientists and clinicians and strengthen the direct interaction between basic research and clinical activities (from bench-to-bedside).

To broadcast information thus acquired at the biannual meetings of the EORTC GU Group and by publication in peer-reviewed scientific journals and a newsletter.

To support and participate in educational efforts by organizing meetings and conferences in the field of urological cancer.